GLOBEALERT

Feed

Open sources, classified and cross-checked. 60+ stories.

SCI & TECHJul 11Japan tests reusable rocket prototype RV-X to reduce costsJapan's space agency tested a prototype of a reusable rocket in Akita Prefecture in the country's northeast on Saturday, paving the way for cutting the costs of future…Japan Today
SCI & TECHJul 6How a Japanese prefecture is managing rising bear population with microchipsA prefecture in western Japan is drawing attention for a unique bear management programme that uses microchips implanted in captured animals to estimate population levels and guide culling decisions, as rising sightings across the country fuel calls for more effective countermeasures. Hyogo prefecture says it is the first in Japan to use information gathered from microchipped bears to determine an appropriate population size and maintain a balance between conservation and population control. The...South China Morning Post
SCI & TECHJul 3Japanese Bio-Lace technology shows strong promise in sewage treatment, says HMWSSBJapanese Bio-Lace technology is showing strong promise for use in sewage treatment, according to HMWSSB. This development could improve waste management processes.The Hindu
SCI & TECHJun 29Civilization VII gets new Japanese empire in latest DLCThe video game Civilization VII is set to receive new downloadable content featuring a Japanese empire. This update expands the available content for players.nichegamer.com · Japan
SCI & TECHJun 25Anthropic's latest hiring points to Australia and Japan as AI infrastructure hubs - reportSeeking Alpha Tech
SCI & TECHJun 20Japan to enhance global cooperation on AI risksThe draft revision of the Artificial Intelligence Basic Plan highlights the growing risk of cyberattacks that exploit AI.japantimes · japan
SCI & TECHJun 18Ag department continues attack on Japanese beetlesThe agriculture department is continuing its efforts to combat Japanese beetles. This news covers ongoing pest control measures in the agricultural sector.elkodaily.com · United States
SCI & TECHJun 18Japan green steel push gains ground but hurdles remain | Hellenic Shipping News WorldwideJapan's initiative to develop "green steel" is making progress, despite facing continuous challenges. This highlights advancements and obstacles in sustainable industrial development.hellenicshippingnews.com · China
SCI & TECHJun 18Check out three new Japanese commercials for Rhythm Heaven GrooveThree new Japanese commercials have been released for the video game 'Rhythm Heaven Groove'.gonintendo · united states of america
SCI & TECHJun 17Assassin Creed Shadows 1 . 0 . 33 for macOS – Epic action ‑ adventure RPG set in feudal Japan with dual protagonistsA new version of the action-adventure RPG 'Assassin's Creed Shadows' has been released for macOS, featuring a feudal Japan setting with dual protagonists.chilecomparte.cl · Chile
SCI & TECHJun 16Pluristyx Announces Patent Allowance of Next Generation Synthetic mRNA Technology in Japan, Solidifying Global iPSC Reprogramming LeadershipPluristyx issued Japan patent allowance for next-gen synthetic mRNA, accelerating non-viral, footprint-free iPSC generation for regenerative medicineglobenewswire_fr · france
SCI & TECHJun 16Pluristyx Announces Patent Allowance of Next Generation Synthetic mRNA Technology in Japan, Solidifying Global iPSC Reprogramming LeadershipSEATTLE, June 16, 2026 (GLOBE NEWSWIRE) -- Pluristyx, a leading provider of advanced induced pluripotent stem cell (iPSC) technologies and proprietary, genetically engineered solutions, today announced the Japanese Patent Office (JPO) issued a Notice of Allowance for Patent Application No. 2023-552219. The licensed patent, titled "Engineered Expression Constructs to Increase Protein Expression from Synthetic Ribonucleic Acid (RNA)" (nationalization of International Application No. PCT/US2022/017880), represents a critical expansion of Pluristyx's intellectual property portfolio. These unique synthetic mRNA constructs stabilize mRNA and increase protein expression without need for modified nucleosides, microRNA sites, or immune-evading factors. This allowance comes at a pivotal moment for regenerative medicine in Japan. A global leader in induced pluripotent stem cell (iPSC) research, Japan established an accelerated regulatory framework for iPSC-derived products in 2015. More than 11 years later, the first two landmark commercial iPSC-derived cell therapies have been approved. Pluristyx is addressing this critical industry bottleneck in the transition from R&D to commercial use by applying its unique synthetic mRNA technology to rapidly generate safe, clinical-grade iPSCs able to be manufactured at large commercial scale. By optimizing expression kinetics of synthetic RNA with a multiplex of key pluripotency transcription factors, the Pluristyx platform ... Full story available on Benzinga.combenzinga · united states of america